Regenerative medicine company Carmell Therapeutics goes public after SPAC merger
Alpha Healthcare Acquisition Corp. III, a special purpose acquisition company (SPAC) headed by Rajiv Shukla, announced the completion of its $328 million merger with Carmell Therapeutics Corporation. Based in Pittsburgh, Pennsylvania, Carmell Therapeutics is a Phase 2 stage regenerative medicine platform company that focuses on the development of plasma-based biomaterials intended for aesthetics, active soft […]